![]() |
Volumn 109, Issue 4, 1998, Pages 444-467
|
Gene therapy: Ovarian carcinoma as the paradigm
a
a,c
|
Author keywords
erbB 2; Gene therapy; Gene transfer; Genetic vector; Integrative vector; Naked DNA; Ovarian neoplasms; Polynucleotide immunization; Replicative viral vector; Single chain antibodies; Targeting; Thymidine kinase; Toxins
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR;
FAS LIGAND;
HERMES ANTIGEN;
RAS PROTEIN;
VASCULOTROPIN;
CANCER GENETICS;
CLONING VECTOR;
GENE THERAPY;
GENE TRANSFER;
HUMAN;
IMMUNOGENETICS;
IMMUNOSTIMULATION;
OVARY CARCINOMA;
PRIORITY JOURNAL;
REVIEW;
TUMOR SUPPRESSOR GENE;
|
EID: 0031921499
PISSN: 00029173
EISSN: None
Source Type: Journal
DOI: 10.1093/ajcp/109.4.444 Document Type: Review |
Times cited : (20)
|
References (12)
|